Current position:Home >Product >
(3R)-1-(4-fluorophenyl)-5-oxidanylidene-N-[2-(propylcarbamoyl)phenyl]pyrrolidine-3-carboxamide
(3R)-1-(4-fluorophenyl)-5-oxidanylidene-N-[2-(propylcarbamoyl)phenyl]pyrrolidine-3-carboxamide
|
|
Canonical SMILES:
CCCNC(=O)C1=CC=CC=C1NC(=O)C2CC(=O)N(C2)C3=CC=C(C=C3)F
Isomeric SMILES
CCCNC(=O)C1=CC=CC=C1NC(=O)[C@@H]2CC(=O)N(C2)C3=CC=C(C=C3)F
InChI
InChI=1S/C21H22FN3O3/c1-2-11-23-21(28)17-5-3-4-6-18(17)24-20(27)14-12-19(26)25(13-14)16-9-7-15(22)8-10-16/h3-10,14H,2,11-13H2,1H3,(H,23,28)(H,24,27)/t14-/m1/s1
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 1-(4-methoxyphenyl)sulfonyl-N-(3-piperidin-1-ium-1-ylpropyl)piperidine-4-carboxamide
- 1-(4-methoxyphenyl)sulfonyl-N-(3-piperidin-1-ylpropyl)piperidine-4-carboxamide
- (5-bromanyl-2-methoxy-phenyl)methyl-methyl-[2-[(4R)-4-methyl-2-oxidanylidene-3,4-dihydro-1H-1,5-benzodiazepin-5-yl]-2-oxidanylidene-ethyl]azanium
- (4R)-5-[2-[(5-bromanyl-2-methoxy-phenyl)methyl-methyl-amino]ethanoyl]-4-methyl-3,4-dihydro-1H-1,5-benzodiazepin-2-one
- (3R)-1-(3-methylphenyl)-N-[2-[(4-methylphenyl)methylcarbamoyl]phenyl]-5-oxidanylidene-pyrrolidine-3-carboxamide
- 1-(3,4-dimethylphenyl)-2-[[5-(methylsulfanylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl]ethanone
- [2-[(3-fluorophenyl)amino]-2-oxidanylidene-ethyl]-methyl-[2-[(5-methyl-2-phenyl-pyrazol-3-yl)amino]-2-oxidanylidene-ethyl]azanium
- ethyl 4-[[(3R,3aS,4S,4aR,5S,9aR)-4a,5-dimethyl-4-oxidanyl-2-oxidanylidene-3,3a,4,5,6,7,9,9a-octahydrobenzo[f][1]benzofuran-3-yl]methyl]piperazin-4-ium-1-carboxylate
- (3R)-1-(4-methylphenyl)-N-[2-[(4-methylphenyl)methylcarbamoyl]phenyl]-5-oxidanylidene-pyrrolidine-3-carboxamide
- 2-[(2S)-1-(1,3-benzodioxol-5-ylamino)-1-oxidanylidene-propan-2-yl]oxy-N-(phenylmethyl)benzamide

